AS 3201 inhibits polyol pathway in diabetic polyneuropathy

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1459, 2004-01, pp. : 6-6

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Polyol pathway, 2,3-diphosphoglycerate in erythrocytes and diabetic neuropathy in rats

By Nakamura J.   Koh N.   Sakakibara F.   Hamada Y.   Wakao T.   Hara T.   Mori K.   Nakashima E.   Naruse K.   Hotta N.  

European Journal of Pharmacology, Vol. 294, Iss. 1, 1995-01 ,pp. : 207-214

Elsevier

Access to resources Recommend Favorite

A novel zwitterionic inhibitor of aldose reductase interferes with polyol pathway in ex vivo and in vivo models of diabetic complications

By  

Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol. 69, Iss. 10, 2014-10 ,pp. : 747-751

Govi-Verlag

Access to resources Recommend Favorite

Thioctic acid beneficial in diabetic polyneuropathy

By  

Inpharma, Vol. 1, Iss. 1425, 2004-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Aldose Reductase / Polyol Inhibitors for Diabetic Retinopathy

By  

Current Pharmaceutical Biotechnology, Vol. 12, Iss. 3, 2011-01 ,pp. : 373-385

Bentham Science Publishers

Access to resources Recommend Favorite

H-reflex and Clinical Examination in the Diagnosis of Diabetic Polyneuropathy

By Millán-Guerrero RO   Trujillo-Hernández B   Isais-Millán S   Prieto-Díaz-Chávez E   Vásquez C   Caballero-Hoyos JR   García-Magaña J  

The Journal of International Medical Research, Vol. 40, Iss. 2, 2012-03 ,pp. : 694-700

Field House Publishing

Access to resources Recommend Favorite